Literature DB >> 28735492

Isolation of Biologically Active Exosomes from Plasma of Patients with Cancer.

Chang-Sook Hong1, Sonja Funk1, Theresa L Whiteside2.   

Abstract

A method for exosome isolation from human plasma was developed for rapid, high-throughput processing of plasma specimens obtained from patients with cancer. This method removes the bulk of plasma proteins associated with exosomes and can be used for comparative examinations of exosomes and their content in serial specimens of patients' plasma, allowing for monitoring changes in exosome numbers, profiles, and functions in the course of cancer progression or during therapy. The plasma-derived exosomes can be recovered in quantities sufficient for the characterization of their morphology by transmission electron microscopy (TEM), size and concentration by qNano, protein/lipid ratios, nucleic acid extraction, molecular profiling by Western blots or immune arrays, and functional assays.

Entities:  

Keywords:  Cancer; Exosome cargo; Exosome functions; Isolation; Plasma exosomes; Size exclusion chromatography

Mesh:

Substances:

Year:  2017        PMID: 28735492     DOI: 10.1007/978-1-4939-7142-8_16

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  15 in total

1.  Transcriptomic Analysis in Liquid Biopsy Identifies Circulating PCTAIRE-1 mRNA as a Biomarker in NSCLC.

Authors:  John Wen-Cheng Chang; Chun-Liang Shih; Chih-Liang Wang; Ji-Dung Luo; Chih-Wei Wang; Jia-Juan Hsieh; Chia-Jung Yu; Chiuan-Chian Chiou
Journal:  Cancer Genomics Proteomics       Date:  2020 Jan-Feb       Impact factor: 4.069

2.  Role of exosomes in hepatocellular carcinoma cell mobility alteration.

Authors:  Sen Wang; Geng Chen; Xiao Lin; Xiaohua Xing; Zhixiong Cai; Xiaolong Liu; Jingfeng Liu
Journal:  Oncol Lett       Date:  2017-10-23       Impact factor: 2.967

Review 3.  Diagnostic and Therapeutic Applications of Exosomes in Cancer with a Special Focus on Head and Neck Squamous Cell Carcinoma (HNSCC).

Authors:  Eliane Ebnoether; Laurent Muller
Journal:  Int J Mol Sci       Date:  2020-06-18       Impact factor: 5.923

4.  Metabolic reprogramming of stromal fibroblasts by melanoma exosome microRNA favours a pre-metastatic microenvironment.

Authors:  Shin La Shu; Yunchen Yang; Cheryl L Allen; Orla Maguire; Hans Minderman; Arindam Sen; Michael J Ciesielski; Katherine A Collins; Peter J Bush; Prashant Singh; Xue Wang; Martin Morgan; Jun Qu; Richard B Bankert; Theresa L Whiteside; Yun Wu; Marc S Ernstoff
Journal:  Sci Rep       Date:  2018-08-27       Impact factor: 4.379

Review 5.  The Role of Exosomes in Pancreatic Cancer.

Authors:  Bin Lan; Siyuan Zeng; Robert Grützmann; Christian Pilarsky
Journal:  Int J Mol Sci       Date:  2019-09-04       Impact factor: 5.923

6.  Melanoma cell-derived exosomes in plasma of melanoma patients suppress functions of immune effector cells.

Authors:  Priyanka Sharma; Brenda Diergaarde; Soldano Ferrone; John M Kirkwood; Theresa L Whiteside
Journal:  Sci Rep       Date:  2020-01-09       Impact factor: 4.379

Review 7.  Progress on pivotal role and application of exosome in lung cancer carcinogenesis, diagnosis, therapy and prognosis.

Authors:  Ming-Yue Li; Li-Zhong Liu; Ming Dong
Journal:  Mol Cancer       Date:  2021-01-27       Impact factor: 27.401

Review 8.  From tumor microenvironment communicants to biomarker discovery: Selectively packaged extracellular vesicular cargoes in pancreatic cancer.

Authors:  Song Han; Patrick Underwood; Steven J Hughes
Journal:  Cytokine Growth Factor Rev       Date:  2020-01-11       Impact factor: 7.638

9.  The potential role of tumor-derived exosomes in diagnosis, prognosis, and response to therapy in cancer.

Authors:  Malgorzata Czystowska-Kuzmicz; Theresa L Whiteside
Journal:  Expert Opin Biol Ther       Date:  2020-09-08       Impact factor: 4.388

10.  Glycan Node Analysis of Plasma-Derived Extracellular Vesicles.

Authors:  Sierra A Walker; Jesús S Aguilar Díaz De León; Sara Busatto; Gregory A Wurtz; Abba C Zubair; Chad R Borges; Joy Wolfram
Journal:  Cells       Date:  2020-08-22       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.